Live Updates: COVID-19 Cases
  • World 11,869,464
    World
    Confirmed: 11,869,464
    Active: 4,497,645
    Recovered: 6,827,674
    Death: 544,145
  • USA 3,078,722
    USA
    Confirmed: 3,078,722
    Active: 1,598,212
    Recovered: 1,346,755
    Death: 133,755
  • Brazil 1,643,539
    Brazil
    Confirmed: 1,643,539
    Active: 505,217
    Recovered: 1,072,229
    Death: 66,093
  • India 743,481
    India
    Confirmed: 743,481
    Active: 265,783
    Recovered: 457,045
    Death: 20,653
  • Russia 694,230
    Russia
    Confirmed: 694,230
    Active: 219,856
    Recovered: 463,880
    Death: 10,494
  • Peru 309,278
    Peru
    Confirmed: 309,278
    Active: 97,388
    Recovered: 200,938
    Death: 10,952
  • Chile 301,019
    Chile
    Confirmed: 301,019
    Active: 26,340
    Recovered: 268,245
    Death: 6,434
  • Spain 299,210
    Spain
    Confirmed: 299,210
    Active: 270,818
    Recovered: ?
    Death: 28,392
  • UK 286,349
    UK
    Confirmed: 286,349
    Active: 241,958
    Recovered: ?
    Death: 44,391
  • Mexico 261,750
    Mexico
    Confirmed: 261,750
    Active: 70,974
    Recovered: 159,657
    Death: 31,119
  • Iran 245,688
    Iran
    Confirmed: 245,688
    Active: 26,757
    Recovered: 207,000
    Death: 11,931
  • Italy 241,956
    Italy
    Confirmed: 241,956
    Active: 14,242
    Recovered: 192,815
    Death: 34,899
  • Pakistan 234,509
    Pakistan
    Confirmed: 234,509
    Active: 94,713
    Recovered: 134,957
    Death: 4,839
  • Saudi Arabia 217,108
    Saudi Arabia
    Confirmed: 217,108
    Active: 60,252
    Recovered: 154,839
    Death: 2,017
  • Turkey 207,897
    Turkey
    Confirmed: 207,897
    Active: 17,345
    Recovered: 185,292
    Death: 5,260
  • South Africa 205,721
    South Africa
    Confirmed: 205,721
    Active: 104,563
    Recovered: 97,848
    Death: 3,310
  • Germany 198,355
    Germany
    Confirmed: 198,355
    Active: 6,552
    Recovered: 182,700
    Death: 9,103
  • France 168,810
    France
    Confirmed: 168,810
    Active: 61,222
    Recovered: 77,655
    Death: 29,933
  • Bangladesh 168,645
    Bangladesh
    Confirmed: 168,645
    Active: 88,392
    Recovered: 78,102
    Death: 2,151
  • Canada 106,106
    Canada
    Confirmed: 106,106
    Active: 27,571
    Recovered: 69,827
    Death: 8,708
  • China 83,565
    China
    Confirmed: 83,565
    Active: 403
    Recovered: 78,528
    Death: 4,634
  • Netherlands 50,694
    Netherlands
    Confirmed: 50,694
    Active: 44,562
    Recovered: ?
    Death: 6,132
  • S. Korea 13,181
    S. Korea
    Confirmed: 13,181
    Active: 982
    Recovered: 11,914
    Death: 285
  • Australia 8,755
    Australia
    Confirmed: 8,755
    Active: 1,194
    Recovered: 7,455
    Death: 106
  • New Zealand 1,536
    New Zealand
    Confirmed: 1,536
    Active: 22
    Recovered: 1,492
    Death: 22

High-level panel formed to recommend reforms in India’s drug regulatory system

Author at TechGenyz India

A high-level committee of experts has been formed by the government to recommend reforms in India's drug regulatory system so that approval processes can be fast-tracked.

Faced with the ominous threat of the coronavirus infection, a number of steps such as fast-tracking the approval process for drugs, research, and vaccine development were taken. A health ministry official said the aim of the panel is to identify and institutionalize these measures.

According to a recent Union Health Ministry order, the committee will study the current drug regulatory system and submit recommendations for reforms, so as to bring the system in line with global standards and make it more efficient.

"The issue of reforms in the Drug Regulatory System has been engaging the attention of the government for quite some time now.

"Although requisite procedural changes have been carried out during the COVID-19 pandemic and have worked quite well, it is felt that comprehensive changes in the drug regulatory regime should be carried out to reflect global best practices as well as domestic requirements, and to streamline Central Drugs Standard Control Organization (CDSCO) to make it more effective," the order issued on May 11 stated.

The committee chaired by Rajesh Bhushan, the OSD to the Union health minister, comprises top drug and vaccine entrepreneurs of India along with officers nominated from the Department of Pharmaceuticals, Department of Biotechnology, Indian Pharmacopoeia Commission, Indian Pharmaceutical Alliance, ICMR along with public health expert from AIIMS.

The order stated, "While nominating a member, the ministries/ departments/ institutions should keep in mind that the officer being nominated should have a flexible approach and willing to consider far-reaching reforms with an open mind."

India's Joint Drug Controller Dr Eswara Reddy will assist the committee in their work on adopting global best practices. The committee, which has met twice till now, will submit its report within one month from the date of its formation.

The committee has been asked by the ministry to also study earlier reports given by the department-related Parliamentary Standing Committee on clinical trials and working of the CDSCO and address the unimplemented recommendations of the previous panels.

We Are Hiring

Subscribe